<bill session="115" type="h" number="6240" updated="2019-10-18T16:07:26Z">
  <state datetime="2018-06-27">REFERRED</state>
  <status>
    <introduced datetime="2018-06-27"/>
  </status>
  <introduced datetime="2018-06-27"/>
  <titles>
    <title type="official" as="introduced">To amend the Public Health Service Act to provide for certain user fees under the 340B drug discount program.</title>
    <title type="short" as="introduced">Drug Discount Accountability Act</title>
    <title type="short" as="introduced">Drug Discount Accountability Act</title>
    <title type="display">Drug Discount Accountability Act</title>
  </titles>
  <sponsor bioguide_id="C001092"/>
  <cosponsors>
    <cosponsor bioguide_id="C001103" joined="2018-06-27"/>
  </cosponsors>
  <actions>
    <action datetime="2018-06-27">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-06-27" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2018-06-27T04:00:00Z" status="Introduced in House">Drug Discount Accountability Act

This bill requires the Health Resources and Services Administration to collect a user fee from certain entities participating in the 340B drug pricing program, including critical access hospitals, for activities relating to program oversight and improvement.</summary>
  <committee-reports/>
</bill>
